Variables . | Total . | RVPAC . | MBTS . | P value . |
---|---|---|---|---|
. | 335 . | 164 (49.0) . | 171 (51.0) . | . |
Norwood procedure, median (IQR) | ||||
Age at Norwood (days) | 8 (7–12) | 8 (7–11) | 9 (7–12) | 0.026 |
Weight at Norwood (kg) | 3.2 (2.9–3.5) | 3.2 (2.9–3.5) | 3.2 (2.8–3.5) | 0.130 |
CPB time (min) | 138 (109–165) | 135 (105–163) | 141 (110–167) | 0.455 |
AXC time (min) | 49 (41–59) | 47 (41–57) | 49 (40–60) | 0.406 |
Postoperative variables | ||||
Intubation (days), median (IQR) | 5 (4–9) | 6 (4–13) | 5 (3–8) | 0.351 |
ICU stay (days), median (IQR) | 13 (8–21) | 14 (10–22) | 12 (8–20) | 0.663 |
HSP stay (days), median (IQR) | 24 (15–37) | 25 (18–37) | 23 (14–40) | 0.234 |
ECMO, n (%) | 46 (13.8) | 23 (14.0) | 23 (13.5) | 0.896 |
Re-intubation, n (%) | 56 (16.8) | 25 (15.3) | 31 (18.2) | 0.480 |
Shunt intervention, n (%) | 50 (15.0) | 29 (17.7) | 21 (12.4) | 0.179 |
Re CoA intervention, n (%) | 19 (5.7) | 10 (6.1) | 9 (5.3) | 0.761 |
Peritoneal dialysis, n (%) | 40 (11.9) | 25 (15.2) | 15 (8.8) | 0.068 |
Necrotizing enterocolitis, n (%) | 22 (6.6) | 7 (4.3) | 15 (8.8) | 0.099 |
Variables . | Total . | RVPAC . | MBTS . | P value . |
---|---|---|---|---|
. | 335 . | 164 (49.0) . | 171 (51.0) . | . |
Norwood procedure, median (IQR) | ||||
Age at Norwood (days) | 8 (7–12) | 8 (7–11) | 9 (7–12) | 0.026 |
Weight at Norwood (kg) | 3.2 (2.9–3.5) | 3.2 (2.9–3.5) | 3.2 (2.8–3.5) | 0.130 |
CPB time (min) | 138 (109–165) | 135 (105–163) | 141 (110–167) | 0.455 |
AXC time (min) | 49 (41–59) | 47 (41–57) | 49 (40–60) | 0.406 |
Postoperative variables | ||||
Intubation (days), median (IQR) | 5 (4–9) | 6 (4–13) | 5 (3–8) | 0.351 |
ICU stay (days), median (IQR) | 13 (8–21) | 14 (10–22) | 12 (8–20) | 0.663 |
HSP stay (days), median (IQR) | 24 (15–37) | 25 (18–37) | 23 (14–40) | 0.234 |
ECMO, n (%) | 46 (13.8) | 23 (14.0) | 23 (13.5) | 0.896 |
Re-intubation, n (%) | 56 (16.8) | 25 (15.3) | 31 (18.2) | 0.480 |
Shunt intervention, n (%) | 50 (15.0) | 29 (17.7) | 21 (12.4) | 0.179 |
Re CoA intervention, n (%) | 19 (5.7) | 10 (6.1) | 9 (5.3) | 0.761 |
Peritoneal dialysis, n (%) | 40 (11.9) | 25 (15.2) | 15 (8.8) | 0.068 |
Necrotizing enterocolitis, n (%) | 22 (6.6) | 7 (4.3) | 15 (8.8) | 0.099 |
AA: aortic atresia; AS: aortic stenosis; AXC: aortic cross clamp; CoA: coarctation of the aorta; CPB: cardiopulmonary bypass; DILV: double inlet left ventricle; ECMO: extracorporeal membrane oxygenation; HSP: hospital; ICU: intensive care unit; IQR: interquartile range; MA: mitral atresia; MBTS: modified Blalock–Taussig shunt; MS: mitral stenosis; RVPAC: right ventricle to pulmonary artery conduit; SV: single ventricle; TA: tricuspid atresia; TAPVC: total anomalous pulmonary venous connection; UAVSD: unbalanced atrioventricular septal defect.
Variables . | Total . | RVPAC . | MBTS . | P value . |
---|---|---|---|---|
. | 335 . | 164 (49.0) . | 171 (51.0) . | . |
Norwood procedure, median (IQR) | ||||
Age at Norwood (days) | 8 (7–12) | 8 (7–11) | 9 (7–12) | 0.026 |
Weight at Norwood (kg) | 3.2 (2.9–3.5) | 3.2 (2.9–3.5) | 3.2 (2.8–3.5) | 0.130 |
CPB time (min) | 138 (109–165) | 135 (105–163) | 141 (110–167) | 0.455 |
AXC time (min) | 49 (41–59) | 47 (41–57) | 49 (40–60) | 0.406 |
Postoperative variables | ||||
Intubation (days), median (IQR) | 5 (4–9) | 6 (4–13) | 5 (3–8) | 0.351 |
ICU stay (days), median (IQR) | 13 (8–21) | 14 (10–22) | 12 (8–20) | 0.663 |
HSP stay (days), median (IQR) | 24 (15–37) | 25 (18–37) | 23 (14–40) | 0.234 |
ECMO, n (%) | 46 (13.8) | 23 (14.0) | 23 (13.5) | 0.896 |
Re-intubation, n (%) | 56 (16.8) | 25 (15.3) | 31 (18.2) | 0.480 |
Shunt intervention, n (%) | 50 (15.0) | 29 (17.7) | 21 (12.4) | 0.179 |
Re CoA intervention, n (%) | 19 (5.7) | 10 (6.1) | 9 (5.3) | 0.761 |
Peritoneal dialysis, n (%) | 40 (11.9) | 25 (15.2) | 15 (8.8) | 0.068 |
Necrotizing enterocolitis, n (%) | 22 (6.6) | 7 (4.3) | 15 (8.8) | 0.099 |
Variables . | Total . | RVPAC . | MBTS . | P value . |
---|---|---|---|---|
. | 335 . | 164 (49.0) . | 171 (51.0) . | . |
Norwood procedure, median (IQR) | ||||
Age at Norwood (days) | 8 (7–12) | 8 (7–11) | 9 (7–12) | 0.026 |
Weight at Norwood (kg) | 3.2 (2.9–3.5) | 3.2 (2.9–3.5) | 3.2 (2.8–3.5) | 0.130 |
CPB time (min) | 138 (109–165) | 135 (105–163) | 141 (110–167) | 0.455 |
AXC time (min) | 49 (41–59) | 47 (41–57) | 49 (40–60) | 0.406 |
Postoperative variables | ||||
Intubation (days), median (IQR) | 5 (4–9) | 6 (4–13) | 5 (3–8) | 0.351 |
ICU stay (days), median (IQR) | 13 (8–21) | 14 (10–22) | 12 (8–20) | 0.663 |
HSP stay (days), median (IQR) | 24 (15–37) | 25 (18–37) | 23 (14–40) | 0.234 |
ECMO, n (%) | 46 (13.8) | 23 (14.0) | 23 (13.5) | 0.896 |
Re-intubation, n (%) | 56 (16.8) | 25 (15.3) | 31 (18.2) | 0.480 |
Shunt intervention, n (%) | 50 (15.0) | 29 (17.7) | 21 (12.4) | 0.179 |
Re CoA intervention, n (%) | 19 (5.7) | 10 (6.1) | 9 (5.3) | 0.761 |
Peritoneal dialysis, n (%) | 40 (11.9) | 25 (15.2) | 15 (8.8) | 0.068 |
Necrotizing enterocolitis, n (%) | 22 (6.6) | 7 (4.3) | 15 (8.8) | 0.099 |
AA: aortic atresia; AS: aortic stenosis; AXC: aortic cross clamp; CoA: coarctation of the aorta; CPB: cardiopulmonary bypass; DILV: double inlet left ventricle; ECMO: extracorporeal membrane oxygenation; HSP: hospital; ICU: intensive care unit; IQR: interquartile range; MA: mitral atresia; MBTS: modified Blalock–Taussig shunt; MS: mitral stenosis; RVPAC: right ventricle to pulmonary artery conduit; SV: single ventricle; TA: tricuspid atresia; TAPVC: total anomalous pulmonary venous connection; UAVSD: unbalanced atrioventricular septal defect.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.